182 related articles for article (PubMed ID: 30680817)
1. Oroxylin A, a methylated metabolite of baicalein, exhibits a stronger inhibitory effect than baicalein on the CYP1B1-mediated carcinogenic estradiol metabolite formation.
An D; Song Z; Yi Y; Zhang Q; Liu J; Zhang Y; Zhou J; Zhao G; Cong D; Li N; Lu Y; Chen X; Zhao D
Phytother Res; 2019 Apr; 33(4):1033-1043. PubMed ID: 30680817
[TBL] [Abstract][Full Text] [Related]
2. Nitidine Chloride-Induced CYP1 Enzyme Inhibition and Alteration of Estradiol Metabolism.
Mao X; Wang J; Wang Q; Yang L; Li Y; Lin H; Peng Y; Zheng J
Drug Metab Dispos; 2019 Aug; 47(8):919-927. PubMed ID: 31147316
[TBL] [Abstract][Full Text] [Related]
3. A methoxyflavonoid, chrysoeriol, selectively inhibits the formation of a carcinogenic estrogen metabolite in MCF-7 breast cancer cells.
Takemura H; Uchiyama H; Ohura T; Sakakibara H; Kuruto R; Amagai T; Shimoi K
J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):70-6. PubMed ID: 19833205
[TBL] [Abstract][Full Text] [Related]
4. The redox protein thioredoxin-1 regulates the constitutive and inducible expression of the estrogen metabolizing cytochromes P450 1B1 and 1A1 in MCF-7 human breast cancer cells.
Husbeck B; Powis G
Carcinogenesis; 2002 Oct; 23(10):1625-30. PubMed ID: 12376470
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells.
Chen ZH; Hurh YJ; Na HK; Kim JH; Chun YJ; Kim DH; Kang KS; Cho MH; Surh YJ
Carcinogenesis; 2004 Oct; 25(10):2005-13. PubMed ID: 15142886
[TBL] [Abstract][Full Text] [Related]
6. Differences in 4-hydroxyestradiol levels in leukocytes are related to CYP1A1(∗)2C, CYP1B1(∗)3 and COMT Val158Met allelic variants.
Martínez-Ramírez OC; Pérez-Morales R; Petrosyan P; Castro-Hernández C; Gonsebatt ME; Rubio J
Steroids; 2015 Oct; 102():1-6. PubMed ID: 26123186
[TBL] [Abstract][Full Text] [Related]
7. Long-term exposure of 4-hydroxyestradiol induces the cancer cell characteristics
Lanxiang W; Bin W; Ge X; Yutang H; Chunjie W; Honghao Z
Toxicol Mech Methods; 2019 Nov; 29(9):686-692. PubMed ID: 31364906
[TBL] [Abstract][Full Text] [Related]
8. Preferential induction of CYP1A1 over CYP1B1 in human breast cancer MCF-7 cells after exposure to berberine.
Wen CJ; Wu LX; Fu LJ; Shen DY; Zhang X; Zhang YW; Yu J; Zhou HH
Asian Pac J Cancer Prev; 2014; 15(1):495-9. PubMed ID: 24528081
[TBL] [Abstract][Full Text] [Related]
9. Phytoestrogens modulate the expression of 17alpha-estradiol metabolizing enzymes in cultured MCF-7 cells.
Wagner J; Jiang L; Lehmann L
Adv Exp Med Biol; 2008; 617():625-32. PubMed ID: 18497090
[TBL] [Abstract][Full Text] [Related]
10. Preferential induction of cytochrome P450 1A1 over cytochrome P450 1B1 in human breast epithelial cells following exposure to quercetin.
Mense SM; Chhabra J; Bhat HK
J Steroid Biochem Mol Biol; 2008 May; 110(1-2):157-62. PubMed ID: 18456490
[TBL] [Abstract][Full Text] [Related]
11. Baicalein inhibits DMBA-DNA adduct formation by modulating CYP1A1 and CYP1B1 activities.
Chan HY; Chen ZY; Tsang DS; Leung LK
Biomed Pharmacother; 2002 Aug; 56(6):269-75. PubMed ID: 12224597
[TBL] [Abstract][Full Text] [Related]
12. 12-O-tetradecanoylphorbol-13-acetate upregulates the Ah receptor and differentially alters CYP1B1 and CYP1A1 expression in MCF-7 breast cancer cells.
Spink BC; Fasco MJ; Gierthy JF; Spink DC
J Cell Biochem; 1998 Sep; 70(3):289-96. PubMed ID: 9706865
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in P450 CYP1B1 affect the conversion of estradiol to the potentially carcinogenic metabolite 4-hydroxyestradiol.
Li DN; Seidel A; Pritchard MP; Wolf CR; Friedberg T
Pharmacogenetics; 2000 Jun; 10(4):343-53. PubMed ID: 10862525
[TBL] [Abstract][Full Text] [Related]
14. Dihydrotanshinone I-Induced CYP1 Enzyme Inhibition and Alteration of Estradiol Metabolism.
Liu Y; Chen Y; Zhang J; Ran G; Cheng Z; Wang X; Liao Y; Mao X; Peng Y; Li W; Zheng J
Drug Metab Dispos; 2024 Feb; 52(3):188-197. PubMed ID: 38123940
[TBL] [Abstract][Full Text] [Related]
15. Induction of cytochrome P450 1B1 and catechol estrogen metabolism in ACHN human renal adenocarcinoma cells.
Spink DC; Spink BC; Cao JQ; Gierthy JF; Hayes CL; Li Y; Sutter TR
J Steroid Biochem Mol Biol; 1997 Jun; 62(2-3):223-32. PubMed ID: 9393958
[TBL] [Abstract][Full Text] [Related]
16. Microsomal hydroxylation of 2- and 4-fluoroestradiol to catechol metabolites and their conversion to methyl ethers: catechol estrogens as possible mediators of hormonal carcinogenesis.
Ashburn SP; Han X; Liehr JG
Mol Pharmacol; 1993 Apr; 43(4):534-41. PubMed ID: 8386306
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of cytochrome P450 1A1 and 1B1 by a combination of dioxin and pesticides in the breast tumor cell line MCF-7.
Coumoul X; Diry M; Robillot C; Barouki R
Cancer Res; 2001 May; 61(10):3942-8. PubMed ID: 11358810
[TBL] [Abstract][Full Text] [Related]
18. Metformin suppresses CYP1A1 and CYP1B1 expression in breast cancer cells by down-regulating aryl hydrocarbon receptor expression.
Do MT; Kim HG; Tran TT; Khanal T; Choi JH; Chung YC; Jeong TC; Jeong HG
Toxicol Appl Pharmacol; 2014 Oct; 280(1):138-48. PubMed ID: 25110054
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450 1B1-mediated estrogen metabolism results in estrogen-deoxyribonucleoside adduct formation.
Belous AR; Hachey DL; Dawling S; Roodi N; Parl FF
Cancer Res; 2007 Jan; 67(2):812-7. PubMed ID: 17234793
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells.
Spink DC; Spink BC; Cao JQ; DePasquale JA; Pentecost BT; Fasco MJ; Li Y; Sutter TR
Carcinogenesis; 1998 Feb; 19(2):291-8. PubMed ID: 9498279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
